ALGIERS, Algeria, November 2, 2011 /PRNewswire/ --
National agreement result of intensive cooperation on defining research community needs
The Ministry of Higher Education & Research of Algeria has chosen Elsevier, the world-leading provider of scientific, technical and medical information products and services, as its main provider of services to help the nation achieve research excellence. The ministry signed multi-year agreements for access to SciVerse ScienceDirect, SciVerse Scopus, Reaxys® and intermediate backfiles.
Algeria aims to play a leading role in fields of research in which the country already performs strongly: chemistry, chemical engineering, material sciences and pharmacology. These multi-year agreements with Elsevier will support this journey. The agreements involve providing access to full text articles on SciVerse ScienceDirect and to intermediate back files for more than 50 universities and research institutes, and access to SciVerse Scopus, the world's largest abstract and citation database for six of the biggest Algerian universities. To support its ambitions in the field of chemistry, the ministry chose to work with Reaxys, the web-based chemistry workflow solution which supports research and fuels discovery.
Professor Hafid Aourag, Director General of Scientific Research of the Ministry of Higher Education, said, "Elsevier has provided us with an extremely valuable source of full text articles, abstracts and citation data, as well as innovative solutions to support Algeria's strategic research objectives. We are confident that these sources and solutions will help us enhance our country's research performance."
Said Taha, Regional Director MEA, Turkey and Central Asia at Elsevier, said, "It has been a pleasure to work together with the ministry over the past months, defining the true needs within the scientific community of Algeria. We are proud to be playing an important role in the research ambitions of an entire nation."
About the Algerian Ministry of Higher Education & Research
The Ministry of Higher Education and Scientific Research is the department responsible for the development and the progress of the academic sector and scientific research in Algeria. To achieve these objectives, the ministry has created two institutions: The Research Centre on Scientific and Technical Information (CERIST) was founded in 1985 with the primary objective to implement programs of scientific research and technological development in the field of information science and technology. The General Directorate for Scientific Research and Technological Development (DG-RSDT) came into being in September 2009, and was set up by law # 08-05 of February 23, 2008, which defines the five-years scientific national research plan (2008-2012), expected to move the Algerian research system to excellency for a sustainable development. By this law, the DG-RSDT is the principal enabler of national scientific research and development.
About the Elsevier SciVerse Suite
The SciVerse (http://www.sciverse.com) suite of search and discovery offerings provides the global research community access to a constantly expanding universe of content and solutions which can now be accessed in one platform. The suite currently includes SciVerse ScienceDirect (http://www.sciencedirect.com), the world's largest source of peer-reviewed content containing more than 10 million articles, and SciVerse Scopus (http://www.scopus.com), an abstract and citation database containing 41 million records, 70% with abstracts and nearly 18,000 titles from 5,000 publishers worldwide. The platform also includes SciVerse Hub beta (http://www.hub.sciverse.com), which enables researchers to perform a single search across all of the SciVerse content as well as targeted web content with results ranked by relevancy and without duplication. SciVerse Applications (http://www.applications.sciverse.com) and Developer Network (http://www.developers.sciverse.com) allow the scientific community to build, find and use applications that enhance the SciVerse research experience.
Reaxys is a workflow solution for research chemists that provides extensive information on chemical compounds, related physical and pharmacological properties, and synthesis information. Researchers can get the experimentally validated information they need in a single overview, from source publications carefully selected for their importance and relevance to research chemists. Elsevier continues to engage with the chemistry community to ensure that Reaxys continues to reflect how chemists think and work. For more information please visit reaxys.com/info.
Reaxys® and the Reaxys® trademark are owned and protected by Elsevier Properties SA. All rights reserved
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Senior Manager Corporate Relations, Elsevier